Eike Staub MSc

Dr. Eike Staub started his bioinformatics career as a Ph.D. student in one of the first oncogenic drug-hunting companies,  metaGen in Berlin. After a short academic research phase focusing on the evolution of protein families and genome content in the post-human genome era as a group lead in the Computational Biology group at the Max Planck Institute for Molecular Genetics in Berlin, he joined Altana Pharma to continue working on oncogenomics for drug research. In 2007 Eike joined Merck KGaA where he worked in various functions to leverage genome-scale data by bioinformatics algorithms, biostatistics, data mining & machine learning for oncology, from identification of drug targets to biomarker assessment in late clinical drug development.

Since 2015 he has been leading Oncology Bioinformatics in the Translational Medicine department at Merck KGaA, a team that is responsible for genome-scale data analysis from early pre-clinical research to late-stage clinical development. His team is also committed to delivering computational infrastructure to enable Merck scientists to conduct biomarker research using self-service tools.